{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:30:25Z","timestamp":1790209825341,"version":"4.1.0"},"reference-count":46,"publisher":"Cambridge University Press (CUP)","issue":"S2","license":[{"start":{"date-parts":[[2007,2,2]],"date-time":"2007-02-02T00:00:00Z","timestamp":1170374400000},"content-version":"unspecified","delay-in-days":124,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parasitology"],"published-print":{"date-parts":[[2006,10]]},"abstract":"<jats:p>Amoebiasis, infection by the protozoan parasite<jats:italic>Entamoeba histolytica<\/jats:italic>, remains a global health problem, despite the availability of effective treatment. While improved sanitation could lead to the eradication of this disease, it is unlikely that this will occur worldwide in the foreseeable future; thus alternative measures must be pursued. One approach is to develop a vaccine to prevent this deadly disease. Clinical studies indicate that mucosal immunity may provide some protection against recurrent intestinal infection with<jats:italic>E. histolytica<\/jats:italic>, but there is no clear evidence that protective immunity develops after amoebic liver abscess. Over the past decade, progress in vaccine development has been facilitated by new animal models that allow better testing of potential vaccine candidates and the application of recombinant technology to vaccine design. Oral vaccines and DNA-based vaccines have been successfully tested in animals models for immunogenicity and efficacy. There has been significant progress on a number of fronts, but there are unanswered questions regarding the effectiveness of immune responses in preventing disease in man and, as yet, no testing of any of these vaccines in humans has been performed. In addition, there are strong economic barriers to developing an amoebiasis vaccine and questions about how and where an effective vaccine would be utilized.<\/jats:p>","DOI":"10.1017\/s003118200600182x","type":"journal-article","created":{"date-parts":[[2007,2,3]],"date-time":"2007-02-03T07:58:45Z","timestamp":1170489525000},"page":"S81-S86","source":"Crossref","is-referenced-by-count":29,"title":["Vaccines for amoebiasis: barriers and opportunities"],"prefix":"10.1017","volume":"133","author":[{"given":"S. L.","family":"STANLEY","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2007,2,2]]},"reference":[{"key":"S003118200600182X_ref024","doi-asserted-by":"crossref","unstructured":"Moran, P. , Ramos, F. , Ramiro, M. , Curiel, O. , Gonzalez, E. , Valadez, A. , Gomez, A. , Garcia, G. , Melendro, E. and Ximenez, C. (2005).Infection by human immunodeficiency virus-1 is not a risk factor for amebiasis.American Journal of Tropical Medicine and Hygiene 73,296\u2013300.","DOI":"10.4269\/ajtmh.2005.73.296"},{"key":"S003118200600182X_ref003","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2002.66.578"},{"key":"S003118200600182X_ref046","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.2.678-683.2004"},{"key":"S003118200600182X_ref033","doi-asserted-by":"publisher","DOI":"10.1086\/322046"},{"key":"S003118200600182X_ref036","doi-asserted-by":"crossref","unstructured":"Sultan, F. , Jin, L. , Jobling, M. G. , Holmes, R. K. and Stanley, S. L. Jr. (1998).Mucosal immunogenicity of a holotoxin-like molecule containing the serine rich Entamoeba histolytica protein (SREHP) fused to the A2 domain of cholera toxin.Infection and Immunity 66,462\u2013468.","DOI":"10.1128\/IAI.66.2.462-468.1998"},{"key":"S003118200600182X_ref044","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00343-6"},{"key":"S003118200600182X_ref043","doi-asserted-by":"crossref","unstructured":"Zhang, T. and Stanley, S. L. Jr. (1996).Oral immunization with an attenuated vaccine strain of Salmonella typhimurium expressing the serine rich Entamoeba histolytica protein (SREHP) induces an anti-amebic immune response and protects gerbils from amebic liver disease.Infection and Immunity 64,1526\u20131531.","DOI":"10.1128\/IAI.64.5.1526-1531.1996"},{"key":"S003118200600182X_ref032","doi-asserted-by":"publisher","DOI":"10.1142\/9781848160583_0007"},{"key":"S003118200600182X_ref037","doi-asserted-by":"publisher","DOI":"10.1111\/j.1550-7408.1995.tb05920.x"},{"key":"S003118200600182X_ref026","unstructured":"Pham, V. L. , Duong, M. H. and Pham, N. H. (1996).Amebic abscess of the liver: ultrasound guided puncture.Annales de Chirurgie 50,340\u2013343."},{"key":"S003118200600182X_ref016","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(84)90115-9"},{"key":"S003118200600182X_ref007","doi-asserted-by":"publisher","DOI":"10.1086\/520355"},{"key":"S003118200600182X_ref042","doi-asserted-by":"crossref","unstructured":"Zhang, T. , Li, E. and Stanley, S. L. Jr. (1995).Oral immunization with the dodecapeptide repeat of the serine rich Entamoeba histolytica protein (SREHP) fused to the cholera toxin B subunit induces a mucosal and systemic anti-SREHP antibody response.Infection and Immunity 63,1349\u20131355.","DOI":"10.1128\/IAI.63.4.1349-1355.1995"},{"key":"S003118200600182X_ref021","unstructured":"Loomis, M. R. , Britt, J. O. , Gendron, A. P. , Holshuh, H. J. and Howard, E. B. (1983).Hepatic and gastric amebiasis in black and white colobus monkeys.JAVMA 11,1188\u20131191."},{"key":"S003118200600182X_ref013","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a117824"},{"key":"S003118200600182X_ref028","doi-asserted-by":"crossref","unstructured":"Ryan, E. T. , Butterton, J. R. , Zhang, T. , Stanley, S. L. Jr. and Calderwood, S. B. (1997).Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine rich Entamoeba histolytica protein (SREHP-12) fused to the cholera toxin B subunit induces systemic and mucosal anti-amebic and anti-V. cholerae antibody responses in mice.Infection and Immunity 65,3118\u20133125.","DOI":"10.1128\/IAI.65.8.3118-3125.1997"},{"key":"S003118200600182X_ref038","unstructured":"Vohra, H. , Kaur, U. , Sharma, A. K. , Bhalla, V. and Bhasin, D. (2003).Effective human defense against E. histolytica: high amoebicidal activity of lymphocytes and monocytes in amoebic liver abscess patients until 3 months follow-up.Parasitology International 52,193\u2013202."},{"key":"S003118200600182X_ref014","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2003.09.003"},{"key":"S003118200600182X_ref012","doi-asserted-by":"publisher","DOI":"10.1086\/341566"},{"key":"S003118200600182X_ref027","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.12.6899-6905.2003"},{"key":"S003118200600182X_ref005","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-7519(03)00268-6"},{"key":"S003118200600182X_ref001","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.2002.00862.x"},{"key":"S003118200600182X_ref002","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1988.39.343"},{"key":"S003118200600182X_ref004","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.1999.01607.x"},{"key":"S003118200600182X_ref006","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1994.50.412"},{"key":"S003118200600182X_ref009","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3024.2003.00607.x"},{"key":"S003118200600182X_ref010","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1999.60.1031"},{"key":"S003118200600182X_ref015","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.74.1.528-536.2006"},{"key":"S003118200600182X_ref017","unstructured":"Jackson, T. F. H. G. , Sargeaunt, P. G. , Visser, P. S. , Gathiram, V. , Suparsad, S. and Anderson, C. B. (1989). Entamoeba histolytica: Naturally occuring infections in baboons.Proceedings of the XI Seminar for Amebiasis 1,73\u201374."},{"key":"S003118200600182X_ref018","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(80)90097-8"},{"key":"S003118200600182X_ref019","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-4758(97)01038-7"},{"key":"S003118200600182X_ref022","unstructured":"Marquez-Monter, H. , Fuentes-Orozco, R. , Correa-Lemus, I. and Becker, I. (1991).Invasive amebiasis in spider monkey (Ateles geoffroyi). Case report and a short review of the literature of amebiasis in non-human primates.Archivos de Investigaci\u00f3n M\u00e9dica (Mexico) 22,75\u201378."},{"key":"S003118200600182X_ref023","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1952.1.417"},{"key":"S003118200600182X_ref025","unstructured":"PAN AMERICAN HEALTH ORGANIZATION. MEXICO (1998). In PAHO, ed. Health in the Americas.Washington, D.C.: p.357\u2013358."},{"key":"S003118200600182X_ref029","doi-asserted-by":"crossref","unstructured":"Soong, C-J. G. , Kain, K. C. , Abd-Alla, M. , Jackson, T. F. H. G. and Ravdin, J. I. (1995 b).A recombinant-cysteine rich section of the Entamoeba histolytica galactose-inhibitable lectin is efficacious as a subunit vaccine in the gerbil model of amebic liver abscess.Journal of Infectious Diseases 171,645\u2013651.","DOI":"10.1093\/infdis\/171.3.645"},{"key":"S003118200600182X_ref030","doi-asserted-by":"crossref","unstructured":"Soong, C-J. G. , Torian, B. E. , Abd-Alla, M. D. , Jackson, T. F. H. G. , Gatharim, V. and Ravdin, J. I. (1995 a).Protection of gerbils from amebic liver abscess by immunization with recombinant Entamoeba histolytica 29-kilodalton antigen.Infection and Immunity 63,472\u2013477.","DOI":"10.1128\/IAI.63.2.472-477.1995"},{"key":"S003118200600182X_ref031","doi-asserted-by":"crossref","unstructured":"Stanley, S. L. Jr. (1997).Progress towards development of a vaccine for amebiasis.Clinical and Microbiological Reviews 10,637\u2013649.","DOI":"10.1128\/CMR.10.4.637"},{"key":"S003118200600182X_ref034","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12830-9"},{"key":"S003118200600182X_ref035","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(95)00001-H"},{"key":"S003118200600182X_ref039","unstructured":"Walker, E. L. and Sellards, A. W. (1913).Experimental entamoebic dysentery.Phillipine Journal of Science B Tropical Medicine 8,253\u2013330."},{"key":"S003118200600182X_ref040","doi-asserted-by":"crossref","unstructured":"Zhang, T. , Cieslak, P. R. , Foster, L. , Kunz-Jenkins, C. and Stanley, S. L. Jr. (1994 b).Antibodies to the serine rich Entamoeba histolytica protein (SREHP) prevent amebic liver abscess in severe combined immunodeficient (SCID) mice.Parasite Immunology 16,225\u2013230.","DOI":"10.1111\/j.1365-3024.1994.tb00344.x"},{"key":"S003118200600182X_ref045","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(97)00042-X"},{"key":"S003118200600182X_ref008","unstructured":"Gathiram, V. and Jackson, T. F. H. G. (1987).A longitudinal study of asymptomatic carriers of pathogenic zymodemes of Entamoeba histolytica .South African Medical Journal 72,669\u2013672."},{"key":"S003118200600182X_ref020","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(06)80032-4"},{"key":"S003118200600182X_ref011","doi-asserted-by":"publisher","DOI":"10.1086\/320740"},{"key":"S003118200600182X_ref041","doi-asserted-by":"crossref","unstructured":"Zhang, T. , Cieslak, P. R. and Stanley, S. L. Jr. (1994 a).Protection of gerbils from amebic liver abscess by immunization with a recombinant Entamoeba histolytica antigen.Infection and Immunity 62,1166\u20131170.","DOI":"10.1128\/IAI.62.4.1166-1170.1994"}],"container-title":["Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S003118200600182X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:06:14Z","timestamp":1587341174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S003118200600182X\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":46,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S003118200600182X"],"URL":"https:\/\/doi.org\/10.1017\/s003118200600182x","relation":{},"ISSN":["0031-1820","1469-8161"],"issn-type":[{"value":"0031-1820","type":"print"},{"value":"1469-8161","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}